Food Anthocyanins and Flavanols as a Strategy for a Healthy Ageing: Cardiovascular Health and Cognitive Performance
NCT ID: NCT04348162
Last Updated: 2021-09-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2017-09-15
2021-05-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Flavonoid Supplementation on Cognition and Neural Mechanisms in Healthy Older Adults
NCT03030053
Effects of Cocoa Flavanols on Human Cognitive Function
NCT01344551
Age-dependent Effects of Flavanols on Vascular Status
NCT01639781
Role of Flavanols In Cardiovascular Function in Healthy Aging
NCT01395277
Cocoa Extract-enriched Meals and Cardiovascular Risk in Older Population
NCT01596309
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Healthy volunteers are recruited to participate in a parallel study (n 30 per group) for 10 to 12 weeks. Markers of cardiovascular health (FMD, markers of inflammation and fatty acid metabolism) and cognition (neuropsychological tests and plasma neurotrophins) are being measured before and after intervention.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cocoa Flavanols
Cocoa is taken every day for 10-12 weeks.
Cocoa flavanols and berries anthocyanins
Effect of cocoa flavanols and berries anthocyanins on cardiovascular and cognitive health
Berries anthocyanins
Red-berries are taken every day for 10-12 weeks.
Cocoa flavanols and berries anthocyanins
Effect of cocoa flavanols and berries anthocyanins on cardiovascular and cognitive health
Cocoa flavanols plus berries anthocyanins
Cooa and red-berries are taken every day for 10-12 weeks.
Cocoa flavanols and berries anthocyanins
Effect of cocoa flavanols and berries anthocyanins on cardiovascular and cognitive health
Control
Normal diet for 10-12 weeks
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cocoa flavanols and berries anthocyanins
Effect of cocoa flavanols and berries anthocyanins on cardiovascular and cognitive health
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI 20-32 Kg/m2
Exclusion Criteria
* Systolic blood pressure (SBP) \>139 mmHg
* Diastolic blood pressure (DBP) \> 89 mmHg
* Total cholesterol \> 6.5 mmol/L
50 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Universitario 12 de Octubre
OTHER
National Research Council, Spain
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Spanish National Research Council
PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute of Food Science, Technology and Nutrition (ICTAN), Spanish National Research Council (CISC)
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AGL2016-76832-R
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.